SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

XRP (XRP) is a cryptocurrency . XRP has a current supply of 99,985,583,260 with 63,516,606,953 in circulation. The last known price of XRP is 1.17847452 USD and is down -3.32 over the last 24 hours. It is currently trading on 1894 active market(s) with $2,362,443,159.56 traded over the last 24 hours. More information can be found at https://xrpl.org/.

Ripple

XRPs prolonged slide and perceived underperformance are driving bearish discussion, with traders citing broader crypto weakness and uncertainty over the Clarity Act after the midterms. Some blame Ripples token sales and question XRPs utility, while others view the decline as a buying opportunity and continue accumulating.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IonQs better-than-expected quarterly results and raised full-year revenue outlook sparked a sharp rally, with traders also pointing to growing backlog and quantum-computing demand. The upbeat reaction is tempered by debate over how much growth came from the SkyWater acquisition, as well as concerns about cash burn, dilution, and whether the gap-up can hold.

Snowflake, Inc. engages in the provision of cloud data warehousing software. The firm offers Data Cloud, an ecosystem where Snowflake customers, partners, data providers, and data consumers can break down data silos and derive value from data. Its platform supports a range of use cases including data warehousing, data lakes, data engineering, data science, data application development, and data sharing. The cloud-native architecture consists of layers across storage, compute, and cloud services. The storage layer ingests structured and semi-structured data to create a unified data record. The compute layer provides dedicated resources to enable users to access common data sets for many use cases without latency. The cloud services layer optimizes each use case's performance requirements with no administration. The company was founded by Marcin Zukowski, Thierry Cruanes, and Benoit Dageville on July 23, 2012 and is headquartered in Menlo Park, CA.

Snowflake Inc

Debate over Snowflakes consumption-based model is driving attention, with traders warning that tighter budgets could lead customers to cut queries, storage and AI workloads, pressuring usage-linked revenue. Others see the models flexibility as a source of recovery when spending improves, while dip buyers and bearish traders remain divided on the stocks direction.

Vertiv Holdings Co. engages in the design, manufacture, and service of critical digital infrastructure technology for data centers, communication networks, and commercial and industrial environments. The firm also offers power management products, switchgear and busbar products, thermal management products, integrated rack systems, modular solutions, and management systems for monitoring and controlling digital infrastructure. It operates through the following geographical segments: Americas, Asia Pacific, and Europe, Middle East, and Africa (EMEA). The Americas segment includes products and services sold for applications within the data center, communication networks and commercial and industrial markets in North America and Latin America. The Asia Pacific segment consists of products and services sold for applications within the data center, communication networks and commercial and industrial markets throughout Greater China, Asia, and India. The EMEA segment focuses on products and services sold for applications within the data center, communication networks, and commercial and industrial markets in Europe, Middle East, and Africa. The company was founded in 1946 and is headquartered in Westerville, OH.

Vertiv Holdings Co - Ordinary Shares - Class A

Vertiv Holdings Co

Vertivs stronger-than-expected quarterly results, raised outlook and more than doubled organic orders sparked a sharp rally, reinforcing optimism about demand for its data-center power and cooling systems. Some traders see confirmation that AI infrastructure spending remains robust, while skeptics point to permitting delays, financing risks and uncertainty over whether orders will translate into delivered revenue.

Salesforce, Inc. engages in the design and development of cloud-based enterprise software for customer relationship management. Its solutions include sales force automation, customer service and support, marketing automation, digital commerce, community management, collaboration, industry-specific solutions, and salesforce platform. The firm also provides guidance, support, training, and advisory services. The company was founded by Marc Russell Benioff and Parker Harris in 1999 and is headquartered in San Francisco, CA.

Salesforce Inc

Salesforces decline is drawing debate over whether it can monetize AI add-ons at renewals when customers may be cutting employee seat counts and software budgets. Traders question whether Agentforce can generate paid demand beyond bundled offers, while others focus on nearby technical support levels.

Strategy, Inc. engages in the development of fixed-income instruments that provide investors varying degrees of economic exposure to bitcoin. It executes bitcoin acquisition, capital management, and capital markets strategies. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

Bitcoins sharp, volatile selloff is driving attention to Strategy as a leveraged BTC proxy, with traders debating whether the weakness could deepen the stocks losses. Bears also cite dilution, preferred-stock obligations and a possible MSCI removal as risks, while bulls argue the pullback is a buying opportunity and look for a rebound.

Arista Networks, Inc. engages in the development, marketing, and sale of cloud networking solutions. Its solutions include EOS, a set of network applications, and Gigabit Ethernet switching and routing platforms. Its product categories include core, cognitive adjacencies, and cognitive networks. The company was founded by Andreas Bechtolsheim, David Cheriton, and Kenneth Duda in November 2004 and is headquartered in Santa Clara, CA.

Arista Networks Inc

Aristas Q3 results beat expectations and its Q4 guidance topped forecasts, strengthening the AI-networking demand story and prompting a sharp rally. Traders are largely bullish on the growth outlook, though some warn that gains may fade and question whether hyperscaler data-center spending can sustain orders.

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. It operates through the following segments: Teladoc Health Integrated Care, BetterHelp, and Others. The Teladoc Health Integrated Care segment offers virtual medical services. The BetterHelp segment includes virtual mental health and other wellness services. The company was founded in June 2002 by George Byron Brooks, Michael Gorton, and Gary Wald and is headquartered in New York, NY.

Teladoc Health Inc

Teladocs Q3 results, with improved profitability and cash generation, fueled a sharp rally and optimism about a turnaround; traders are also pointing to analyst upgrades and speculating about a short squeeze. Others remain cautious, citing declining revenue and ongoing BetterHelp challenges, while some see the latest pullback as profit-taking after the run.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

Celsius drew attention after reporting a better-than-expected third quarter, with Alani Nu and international growth offsetting a decline in the flagship Celsius brand. Traders welcomed the beat but debated whether Alani can sustain portfolio growth, while margin compression and core-brand weakness tempered optimism.

Chewy, Inc. operates as an online retailer of pet food and other pet-related products and services. It supplies pet medications, food, treats and other pet-health products and services for dogs, cats, fish, birds, small pets, horses, and reptiles. It has a portfolio of pet healthcare offerings that includes Chewy Pharmacy, Connect with a Vet, and CarePlus, an exclusive suite of pet-first insurance and wellness plans. The company was founded by Ryan Cohen and Michael Day in September 2011 and is headquartered in Plantation, FL.

Chewy Inc - Ordinary Shares - Class A

Chewy Inc

Chewys post-earnings selloff is dominating discussion: traders point to soft organic growth, margin concerns and weaker quarterly free cash flow despite a raised full-year sales outlook. Bulls view the drop as an overreaction to a still-profitable business, while bears see persistent consumer weakness and limited growth as reasons for caution.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

A tiny GLP-1 implant is the latest bet to help patients maintain their weight loss

Vivani Medical is developing an implant of semaglutide, the active ingredient in Novo Nordisk's obesity injection Wegovy and diabetes counterpart Ozempic...

Vivani Scores Major Validation as Novo Nordisk Evaluates Its Ultra Long-Acting Semaglutide Platform

Vivani Medical (NASDAQ:VANI) has taken another step toward advancing its long-acting obesity treatment platform by entering into an agreement with Novo Nordisk, one of the global leaders in GLP-1 therapies. Under the agreement, Novo Nordisk will conduct a non-exclusive internal evaluation of Vivani's investigational semaglutide implant, NPM-139, highlighting growing industry interest in alternative drug delivery technologies for chronic weight management.

Why Did CLRO Stock Surge More Than 170% Today?

Equity

ClearOne is executing a reverse merger with a company developing brain implant devices.

ClearOne Announces Entry into Merger Agreement with Cortigent, Inc., a Wholly-Owned Subsidiary of Vivani Medical

ClearOne, Inc. (Nasdaq: CLRO) (ClearOne) announced today that it has entered into a definitive agreement and plan of merger (the Agreement) among its wholly-owned subsidiary (MergerSub), Vivani Medical, Inc. (Nasdaq: VANI; Vivani), and Cortigent, Inc. (Cortigent), a wholly-owned subsidiary of...

Vivani Medical (VANI) to Release Quarterly Earnings on Tuesday

Vivani Medical (NASDAQ:VANI) will be releasing its Q1 2026 earnings before the market opens on Tuesday, May 12. (View Earnings Report at...

Vivani Medical (NASDAQ:VANI) Director Gregg Williams Purchases 1,587,301 Shares

Vivani Medical, Inc. (NASDAQ:VANI - Get Free Report) Director Gregg Williams purchased 1,587,301 shares of the company's stock in a transaction that occurred on Wednesday, April 15th. The stock was...

Vivani Medical (NASDAQ:VANI) Director Gregg Williams Acquires 1,587,301 Shares

Vivani Medical, Inc. (NASDAQ:VANI - Get Free Report) Director Gregg Williams purchased 1,587,301 shares of the firm's stock in a transaction on Wednesday, April 15th. The shares were purchased at an...

Vivani Medical, Inc. (NASDAQ:VANI) Sees Large Increase in Short Interest

Vivani Medical, Inc. (NASDAQ:VANI - Get Free Report) saw a significant growth in short interest in March. As of March 31st, there was short interest totaling 532,131 shares, a growth of 65.0% from the March 15th total of 322,575 shares. Currently, 1.2% of the company's stock are sold short. Based...

Vivani Medical (VANI) Upgraded to Buy: What Does It Mean for the Stock?

Vivani Medical (VANI) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

HC Wainwright Lifts Earnings Estimates for Vivani Medical

Vivani Medical, Inc. (NASDAQ:VANI - Free Report) - Stock analysts at HC Wainwright increased their Q1 2026 EPS estimates for Vivani Medical in a research note issued to investors on Tuesday, March 31st. HC Wainwright analyst Y. Chen now forecasts that the company will post earnings of ($0.08) per sh...

This account has been verified as an official VANI representative.

Verified Account

Vivani Medical

Vivani Medical, Inc. is a preclinical stage biopharmaceutical company, which engages in the business of developing miniaturized, subdermal implants utilizing proprietary NanoPortal technology to enable long-term, near constant-rate delivery of a broad range of medicines to treat chronic diseases. It operates under the Biopharm Division and Neuromodulation Division segments. The company was founded by Adam Mendelsohn on May 22, 2003 and is headquartered in Alameda, CA.

Vivani Medical Inc

Bearish Sentiment

<ul class="summary-bullets"><li>In October last year, ClearOne divested its legacy assets to Biamp as part of a strategic pivot into the medical technology field.</li><li>At the end of the transaction, former ClearOne shareholders will own about 12.7% to 14.4% of the new entity.</li><li>Additionally, ClearOne is also looking to raise up to $15 million concurrently with the closing of the deal.</li></ul>Shares of ClearOne (CLRO) skyrocketed on Thursday after the company announced a reverse merger agreement with Vivani Medical’s (VANI) unit Cortigent.At the time of writing, CLRO stock was up more than 170%.<h2 class="st-heading-2">Why Is CLRO Reverse Merging With Cortigent?</h2>ClearOne used to be in the communications equipment business, primarily dealing in audio and video conferencing products. In October last year, the company divested its legacy assets to Biamp as part of a strategic pivot into the medical technology field.The company is currently serving as a public vehicle for Cortigent, which is developing brain-implant devices to help patients recover critical bodily functions.“I am excited to announce this transaction. In my view, Cortigent's mission, to help patients recover sight and motor function through precision neurostimulation, is compelling given both the technical outlook for their neurostimulation technology and the significant unmet market needs that this technology seeks to address,” said ClearOne Chairman Eric Robinson.<h2 class="st-heading-2">Terms Of The Deal</h2>Under the terms of the deal, Vivani will receive 12.5 million shares of ClearOne and gain a controlling stake of between 59.4% and 67.5% in the combined entity, while former ClearOne shareholders will own about 12.7% to 14.4% of the company.Cortigent will be the surviving entity in the transaction, with the combined entity renamed Cortigent Holdings, Inc., the Nasdaq ticker symbol changing to “CRGT,” and a newly appointed board of directors.Additionally, ClearOne is looking to raise up to $15 million concurrently with the closing of the deal, which will “give the combined company a strong foundation to move its pipeline forward.”The transaction is expected in the third quarter of this year.<h2 class="st-heading-2">What Retail Traders Think About CLRO</h2>On Stocktwits, retail sentiment toward the stock turned ‘extremely bullish’ from ‘bearish’ over the last 24 hours.<a href="https://stocktwits.com/symbol/CLRO">CLRO shares</a> have gained 79% this year.For updates and corrections, email newsroom[at]stocktwits[dot]com

Rising stock market chart on a trading board background. (Source: Getty Images)

Shares of ClearOne (CLRO) skyrocketed on Thursday after the company announced a reverse merger agreement with Vivani Medical’s (VANI) unit Cortigent.

ClearOne Inc

Up more than 1% 

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$1.07
Prev Close	$1.04
Open	$1.04
Dividend Yield	0.00%
50-Day Moving Average	$1.21
Beta	0.87
Avg. Volume	166,893.97
PE Ratio	-3.00

52-Week High	$1.66
52-Week Low	$0.9228
Market Capitalization	$93.81M
EPS (Annual)	-$0.4265
Price to Book	5.04
Revenue Per Employee	$0.00

Feed

News

Sentiment

Earnings

Fundamentals

Info

VANI Fundamentals